What protections does new Massachusetts legislation offer 340B providers against PBMs?
A recent bill sponsored by Rep. Sean Reid and Sen. Jason Lewis aims to protect 340B providers from discriminatory practices by pharmacy benefit managers in the commercial market. This legislative move follows approaches adopted in other states to ensure that hospitals and health systems can retain discounts on outpatient drugs.
✓ Accepted answer
The new Massachusetts legislation protects 340B providers by prohibiting pharmacy benefit managers (PBMs) from engaging in discriminatory practices that interfere with commercial market access to discounted outpatient drugs.
- Prohibition on Discriminatory Pricing: The bill, sponsored by Representative Sean Reid and Senator Jason Lewis, explicitly bans PBMs from applying lower reimbursement rates or denial codes to drugs dispensed by 340B entities when compared to non-discounted hospitals. This ensures that hospitals can retain the full financial benefit of the 340B Drug Pricing Program, which helps offset rising medication costs for safety-net patients.
- Transparency and Audit Rights: The legislation mandates that PBMs provide clear audit trails and transparent data regarding how they process claims for 340B providers. This allows health systems to verify that no improper clawbacks or retroactive billing adjustments are applied, a common challenge in complex reimbursement cycles.
- Statewide Advocacy Support: The Massachusetts Health & Hospital Association actively supports this initiative, highlighting that such protections are critical for keeping hospital doors open and maintaining affordable care access for communities that rely on charitable care.
- Alignment with Federal Oversight: These state-level protections complement federal efforts managed by the Healthcare Systems Bureau within the Health Resources and Services Administration. By ensuring 340B discounts are not eroded by commercial PBM tactics, the bill supports the broader federal goal of ensuring equitable access to low-cost medications for vulnerable populations.
- Practical Impact for Providers: For hospital pharmacists and revenue cycle teams, this law reduces the administrative burden of fighting PBM rejections. It creates a more stable reimbursement environment, allowing providers to reinvest savings directly into patient care rather than legal fees or dispute resolution processes.
Related Questions
- What is Paw Paw Mail and who is it designed for?
- How does long-term amiodarone use affect the optic nerve in elderly patients?
- How much does a $500,000 20-year term life insurance policy cost monthly in 2026?
- What small appliances work best for meal prep in a two-burner kitchen?
- What percentage of consumers say social content influences how they discover new brands?